Drug reference

Calcitriol

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 1353

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Mild to moderate plaque psoriasis ▶TO THE SKIN ▶Adult: Apply twice daily, not more than 35% of body surface to be treated daily; maximum 30 g per day

PDF page 1353

Contra Indications

Do not apply under occlusion. patients with calcium metabolism disorders

PDF page 1353

Cautions

Erythrodermic exfoliative psoriasis (enhanced risk of hypercalcaemia). generalised pustular psoriasis (enhanced risk of hypercalcaemia)

PDF page 1353

Safety

Interactions

→Appendix 1: vitamin D substances

PDF page 1353

Pregnancy

Manufacturer advises use in restricted amounts only if clearly necessary. Monitoring Monitor urine- and serum-calcium concentration in pregnancy.

PDF page 1353

Breast Feeding

Manufacturer advises avoid.

PDF page 1353

Hepatic Impairment

Manufacturer advises avoid.

PDF page 1353

Renal Impairment

Manufacturer advises avoid—no information available. l HANDLING AND STORAGE Hands should be washed thoroughly after application to avoid inadvertent transfer to other body areas.

PDF page 1353

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Ointment ▶Silkis (Galderma (UK) Ltd) Calcitriol 3 microgram per 1 gram Silkis ointment | 100 gram P £18.06 DT = £18.06

PDF page 1353

Dose text by age group

Adult

Apply twice daily, not more than 35% of body

First-line fragment. Read the complete Indications and Dose section above.

PDF page 1353

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Calcitriol

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 1353

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Mild to moderate plaque psoriasis ▶TO THE SKIN ▶Adult: Apply twice daily, not more than 35% of body surface to be treated daily; maximum 30 g per day

PDF page 1353

Contra Indications

Do not apply under occlusion. patients with calcium metabolism disorders

PDF page 1353

Cautions

Erythrodermic exfoliative psoriasis (enhanced risk of hypercalcaemia). generalised pustular psoriasis (enhanced risk of hypercalcaemia)

PDF page 1353

Safety

Interactions

→Appendix 1: vitamin D substances

PDF page 1353

Pregnancy

Manufacturer advises use in restricted amounts only if clearly necessary. Monitoring Monitor urine- and serum-calcium concentration in pregnancy.

PDF page 1353

Breast Feeding

Manufacturer advises avoid.

PDF page 1353

Hepatic Impairment

Manufacturer advises avoid.

PDF page 1353

Renal Impairment

Manufacturer advises avoid—no information available. l HANDLING AND STORAGE Hands should be washed thoroughly after application to avoid inadvertent transfer to other body areas.

PDF page 1353

Dose and formulations

Medicinal Forms

PDF page 1353

Dose text by age group

Adult

Apply twice daily, not more than 35% of body

First-line fragment. Read the complete Indications and Dose section above.

PDF page 1353

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.